S&P 500   3,804.36 (+0.35%)
DOW   30,433.99 (+0.39%)
QQQ   282.02 (-0.04%)
AAPL   146.33 (+0.16%)
MSFT   249.37 (+0.20%)
META   138.97 (-0.93%)
GOOGL   101.19 (-0.44%)
AMZN   120.96 (-0.11%)
TSLA   239.72 (-3.90%)
NVDA   131.87 (+0.15%)
NIO   15.99 (-4.42%)
BABA   84.46 (+0.42%)
AMD   68.04 (+0.21%)
T   15.95 (-0.87%)
MU   54.75 (+1.46%)
CGC   3.03 (-3.50%)
F   12.46 (+0.81%)
GE   67.87 (+0.49%)
DIS   100.44 (-0.99%)
AMC   7.43 (-5.11%)
PYPL   93.98 (+1.28%)
PFE   44.15 (-0.70%)
NFLX   236.21 (-1.88%)
S&P 500   3,804.36 (+0.35%)
DOW   30,433.99 (+0.39%)
QQQ   282.02 (-0.04%)
AAPL   146.33 (+0.16%)
MSFT   249.37 (+0.20%)
META   138.97 (-0.93%)
GOOGL   101.19 (-0.44%)
AMZN   120.96 (-0.11%)
TSLA   239.72 (-3.90%)
NVDA   131.87 (+0.15%)
NIO   15.99 (-4.42%)
BABA   84.46 (+0.42%)
AMD   68.04 (+0.21%)
T   15.95 (-0.87%)
MU   54.75 (+1.46%)
CGC   3.03 (-3.50%)
F   12.46 (+0.81%)
GE   67.87 (+0.49%)
DIS   100.44 (-0.99%)
AMC   7.43 (-5.11%)
PYPL   93.98 (+1.28%)
PFE   44.15 (-0.70%)
NFLX   236.21 (-1.88%)
S&P 500   3,804.36 (+0.35%)
DOW   30,433.99 (+0.39%)
QQQ   282.02 (-0.04%)
AAPL   146.33 (+0.16%)
MSFT   249.37 (+0.20%)
META   138.97 (-0.93%)
GOOGL   101.19 (-0.44%)
AMZN   120.96 (-0.11%)
TSLA   239.72 (-3.90%)
NVDA   131.87 (+0.15%)
NIO   15.99 (-4.42%)
BABA   84.46 (+0.42%)
AMD   68.04 (+0.21%)
T   15.95 (-0.87%)
MU   54.75 (+1.46%)
CGC   3.03 (-3.50%)
F   12.46 (+0.81%)
GE   67.87 (+0.49%)
DIS   100.44 (-0.99%)
AMC   7.43 (-5.11%)
PYPL   93.98 (+1.28%)
PFE   44.15 (-0.70%)
NFLX   236.21 (-1.88%)
S&P 500   3,804.36 (+0.35%)
DOW   30,433.99 (+0.39%)
QQQ   282.02 (-0.04%)
AAPL   146.33 (+0.16%)
MSFT   249.37 (+0.20%)
META   138.97 (-0.93%)
GOOGL   101.19 (-0.44%)
AMZN   120.96 (-0.11%)
TSLA   239.72 (-3.90%)
NVDA   131.87 (+0.15%)
NIO   15.99 (-4.42%)
BABA   84.46 (+0.42%)
AMD   68.04 (+0.21%)
T   15.95 (-0.87%)
MU   54.75 (+1.46%)
CGC   3.03 (-3.50%)
F   12.46 (+0.81%)
GE   67.87 (+0.49%)
DIS   100.44 (-0.99%)
AMC   7.43 (-5.11%)
PYPL   93.98 (+1.28%)
PFE   44.15 (-0.70%)
NFLX   236.21 (-1.88%)
NASDAQ:CHRS

Coherus BioSciences - CHRS SEC Filings & 10K Form

$9.75
-0.32 (-3.18%)
(As of 10/5/2022 03:03 PM ET)
Add
Compare
Today's Range
$9.65
$10.01
50-Day Range
$8.09
$13.87
52-Week Range
$5.60
$19.32
Volume
25,854 shs
Average Volume
1.16 million shs
Market Capitalization
$757.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00

Recent Coherus BioSciences SEC Filings

DateFilerForm TypeView
09/15/2022
3:34 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2022
4:37 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2022
4:36 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/09/2022
3:46 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2022
3:35 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2022
3:25 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2022
4:18 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2022
3:50 PM
Coherus BioSciences (Issuer)
O'Donnell-Tormey Jill (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/06/2022
5:50 PM
Coherus BioSciences (Issuer)
Newton Charles W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2022
5:47 PM
Coherus BioSciences (Issuer)
Newton Charles W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/06/2022
5:43 PM
Coherus BioSciences (Issuer)
Newton Charles W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2021
3:19 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
3:06 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2021
4:19 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
4:11 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2021
5:05 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
3:31 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
3:24 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2021
3:08 PM
Coherus BioSciences (Filer)
Form DEFA14A
03/16/2021
5:10 PM
Coherus BioSciences (Issuer)
Stilwell McDavid (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2021
4:37 PM
Coherus BioSciences (Issuer)
Vexler Vladimir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
3:24 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:18 PM
Coherus BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
2:36 PM
Coherus BioSciences (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/10/2021
9:46 AM
Coherus BioSciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/08/2021
7:30 AM
Coherus BioSciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/03/2021
4:39 PM
Coherus BioSciences (Issuer)
Vexler Vladimir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:38 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:37 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
7:45 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2021
3:15 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
3:37 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
1:22 PM
Coherus BioSciences (Subject)
Form SC 13G/A
01/21/2021
3:22 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:31 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:30 PM
Coherus BioSciences (Issuer)
HEALY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:29 PM
Coherus BioSciences (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:27 PM
Coherus BioSciences (Issuer)
TZOUMAKAS KIMBERLY JO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:26 PM
Coherus BioSciences (Issuer)
NUSSBAUM SAMUEL R MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:25 PM
Coherus BioSciences (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:24 PM
Coherus BioSciences (Issuer)
Vexler Vladimir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:23 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
3:22 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
10:43 AM
Coherus BioSciences (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
01/07/2021
3:32 PM
Coherus BioSciences (Issuer)
STOLPER MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:32 PM
Coherus BioSciences (Issuer)
STOLPER MARK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2021
3:31 PM
Coherus BioSciences (Issuer)
MENDELSON ALAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:30 PM
Coherus BioSciences (Issuer)
MENDELSON ALAN C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2021
3:15 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
3:19 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/04/2021
3:10 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/21/2020
3:10 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:39 PM
Coherus BioSciences (Issuer)
Vexler Vladimir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
4:53 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:51 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
3:16 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
3:16 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:06 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2020
3:04 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
3:19 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2020
3:30 PM
Coherus BioSciences (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
09/21/2020
4:06 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:46 PM
Coherus BioSciences (Issuer)
HEALY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
3:23 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:19 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
3:07 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2020
4:04 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
4:58 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:55 PM
Coherus BioSciences (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:35 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:33 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
12:29 PM
Coherus BioSciences (Filer)
Form CT ORDER
05/12/2020
5:30 AM
Coherus BioSciences (Filer)
Form DEFA14A
05/07/2020
3:33 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/14/2020
6:43 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
4:06 PM
Coherus BioSciences (Filer)
Form DEF 14A
02/21/2020
5:16 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:00 AM
Coherus BioSciences (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
01/24/2020
3:46 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/24/2020
3:42 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/22/2020
3:06 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:11 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
9:00 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
4:55 PM
Coherus BioSciences (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:54 PM
Coherus BioSciences (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:54 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:53 PM
Coherus BioSciences (Issuer)
HEALY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:52 PM
Coherus BioSciences (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:52 PM
Coherus BioSciences (Issuer)
Richards Christos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:51 PM
Coherus BioSciences (Issuer)
NUSSBAUM SAMUEL R MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:50 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:49 PM
Coherus BioSciences (Issuer)
Vexler Vladimir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:48 PM
Coherus BioSciences (Issuer)
Viret Jean-Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:48 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
3:45 PM
Coherus BioSciences (Issuer)
HEALY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
9:24 AM
Coherus BioSciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/08/2020
4:41 PM
Coherus BioSciences (Issuer)
Fullerton Management Pte Ltd (Reporting)
Temasek Holdings Ltd (0001021944) (Reporting)
Temasek Life Sciences Private Ltd (Reporting)
V-Sciences Investments Pte Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2020
1:29 PM
Coherus BioSciences (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
12/18/2019
3:28 PM
Anicetti Vincent R (Reporting)
Coherus BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:56 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:CHRS) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.